Skin Cancer Excision Site, Skin Graft, Split Thickness Skin Graft
Conditions
Brief summary
The purpose of this study is to evaluate the efficacy of the Spiracur SNaP® Wound Care System for the treatment of skin cancer excision sites and split thickness skin grafts (STSG). The secondary purpose will be to compare the prospective patients to retrospectively treated skin cancer excision sites and STSGs to further evaluate efficacy and safety.
Interventions
DEVICESNaP® Wound Care System
Wound dressing applications using customized system. Dressing applications changes per manufacturer recommendation.
Sponsors
3M
Solventum US LLC
Study design
Observational model
COHORT
Time perspective
OTHER
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Skin cancer excision site and/or STSG as the source of the wound on any part of the body including head and neck, torso, and extremities. Any other type of skin graft will also be eligible for inclusion into the study. * Wound \< 16 cm in greatest diameter * Subject ≥ 18 years of age * Female subjects of child-bearing potential must be willing to take a urine pregnancy test prior to starting study * Subject is willing and able to sign informed consent
Exclusion criteria
* Wound-related cellulitis * Wound located in an area not amenable to forming an air-tight seal * Subject has untreated osteomyelitis * Subject is allergic to wound care products * Wound has exposed blood vessels not suitable for negative pressure therapy * Subject is actively participating in other clinical trials that conflict with current study * Subject has fistulas * Subject is pregnant
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Wound Closure | 12 weeks |
Countries
United States
Outcome results
None listed